Aristada 441 mg
Drug
Alkermes, Inc.
Total Payments
$14.4M
Transactions
48,768
Doctors
7,740
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $7.2M | 24,616 | 5,383 |
| 2017 | $7.2M | 24,152 | 5,638 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10.9M | 3,571 | 75.8% |
| Travel and Lodging | $1.5M | 5,448 | 10.3% |
| Food and Beverage | $1.3M | 39,232 | 8.9% |
| Consulting Fee | $419,987 | 97 | 2.9% |
| Grant | $286,250 | 13 | 2.0% |
| Gift | $4,888 | 198 | 0.0% |
| Education | $875.70 | 209 | 0.0% |
Top Doctors Receiving Payments for Aristada 441 mg
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD, MPH | Psychiatry | Pomona, NY | $320,333 | 293 |
| Monte Buchsbaum | — | San Diego, CA | $287,870 | 31 |
| , M.D., PH.D | Psychiatry | Detroit, MI | $259,284 | 203 |
| , M.D | Psychiatry | Albuquerque, NM | $236,069 | 241 |
| , M.D | Psychiatry | Costa Mesa, CA | $217,516 | 192 |
| , MD | Psychiatry | Saint Louis, MO | $215,886 | 207 |
| , MD | Psychiatry | Pittsburgh, PA | $213,562 | 258 |
| , M.D | Psychiatry | Bronx, NY | $209,485 | 220 |
| , M.D | Psychiatry | Katy, TX | $207,610 | 323 |
| , MD | Psychiatry | Lake Jackson, TX | $206,254 | 200 |
| , M.D | Psychiatry | New York, NY | $205,821 | 227 |
| , M.D | Psychiatry | Bloomfield Hills, MI | $203,112 | 202 |
| , M.D | Psychiatry | Los Gatos, CA | $195,258 | 282 |
| , M.D | Psychiatry | Elizabethtown, KY | $191,958 | 239 |
| , M.D | Psychiatry | Loganville, GA | $190,259 | 191 |
| , MD | Psychiatry | Bartlett, TN | $189,012 | 180 |
| , M.D | Psychiatry | Midvale, UT | $188,274 | 182 |
| , M.D | Psychiatry | Glen Allen, VA | $186,991 | 209 |
| , MD | Psychiatry | Durham, NC | $182,857 | 225 |
| , M.D | Psychiatry | Coral Gables, FL | $182,814 | 211 |
| , MD | Psychiatry | Canton, OH | $180,273 | 264 |
| , MD | Specialist | Columbus, OH | $179,486 | 184 |
| , M.D | Internal Medicine | Hickory, NC | $176,946 | 191 |
| , M.B.B.S | Psychiatry | Omaha, NE | $165,907 | 159 |
| , MD | Psychiatry | Ocala, FL | $151,966 | 153 |
Ad
Manufacturing Companies
- Alkermes, Inc. $14.4M
Product Information
- Type Drug
- Total Payments $14.4M
- Total Doctors 7,740
- Transactions 48,768
About Aristada 441 mg
Aristada 441 mg is a drug associated with $14.4M in payments to 7,740 healthcare providers, recorded across 48,768 transactions in the CMS Open Payments database. The primary manufacturer is Alkermes, Inc..
Payment data is available from 2017 to 2018. In 2018, $7.2M was paid across 24,616 transactions to 5,383 doctors.
The most common payment nature for Aristada 441 mg is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($10.9M, 75.8% of total).